Sino Medical Sciences Technology Inc. (688108.SS)
CNY 9.07
(0.0%)
CNY 9.07
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -69.13 Million CNY | 65.43% |
| 2022 | -200.01 Million CNY | -28.15% |
| 2021 | -156.07 Million CNY | -1115.93% |
| 2020 | 15.36 Million CNY | -85.85% |
| 2019 | 108.58 Million CNY | 0.23% |
| 2018 | 108.33 Million CNY | 31.56% |
| 2017 | 82.34 Million CNY | 116.62% |
| 2016 | 38.01 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | -11.81 Million CNY | -13829.26% |
| 2024 Q1 | -26.15 Million CNY | -96.4% |
| 2024 Q2 | 86.09 Thousand CNY | 100.33% |
| 2023 Q4 | -13.31 Million CNY | 13.29% |
| 2023 Q2 | -16.13 Million CNY | 33.7% |
| 2023 FY | -69.13 Million CNY | 65.43% |
| 2023 Q3 | -15.35 Million CNY | 4.81% |
| 2023 Q1 | -24.33 Million CNY | 67.66% |
| 2022 Q3 | -43.86 Million CNY | 19.41% |
| 2022 FY | -200.01 Million CNY | -28.15% |
| 2022 Q4 | -75.24 Million CNY | -71.52% |
| 2022 Q2 | -54.43 Million CNY | -46.58% |
| 2022 Q1 | -37.13 Million CNY | -15.3% |
| 2021 Q3 | -41.56 Million CNY | 7.1% |
| 2021 Q2 | -44.73 Million CNY | 0.06% |
| 2021 Q4 | -32.2 Million CNY | 22.51% |
| 2021 FY | -156.07 Million CNY | -1115.93% |
| 2021 Q1 | -44.76 Million CNY | -45.58% |
| 2020 FY | 15.36 Million CNY | -85.85% |
| 2020 Q4 | -30.75 Million CNY | -302.27% |
| 2020 Q3 | 15.2 Million CNY | -44.82% |
| 2020 Q2 | 27.55 Million CNY | 129.49% |
| 2020 Q1 | 12 Million CNY | -61.03% |
| 2019 FY | 108.58 Million CNY | 0.23% |
| 2019 Q2 | 28.22 Million CNY | -0.52% |
| 2019 Q1 | 28.36 Million CNY | -0.28% |
| 2019 Q4 | 30.81 Million CNY | 45.46% |
| 2019 Q3 | 21.18 Million CNY | -24.94% |
| 2018 Q4 | 28.44 Million CNY | 0.0% |
| 2018 Q1 | 30.64 Million CNY | 0.0% |
| 2018 FY | 108.33 Million CNY | 31.56% |
| 2017 FY | 82.34 Million CNY | 116.62% |
| 2016 FY | 38.01 Million CNY | 0.0% |